Evaluation of lung tumor perfusion by dynamic contrast-enhanced MRI
✍ Scribed by Sandra Pauls; Felix M. Mottaghy; Stefan A. Schmidt; Stefan Krüger; Peter Möller; Hans-Jürgen Brambs; Arthur Wunderlich
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 408 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0730-725X
No coin nor oath required. For personal study only.
✦ Synopsis
The characterization of solid pulmonary lesions with imaging methods remains a diagnostic challenge. The aim of this study was to correlate kinetic parameters of dynamic perfusion magnetic resonance imaging (MRI) with histological tumor classification. Dynamic contrast-enhanced MRI of 31 patients with pulmonary masses (five benign lesions, 26 malignant tumors) was acquired in the tumor areas every 20 s for a mean duration of 124 s. Contrast uptake (CU) was measured by signal analysis in regions of interest (ROIs). The beginning and duration of CU, maximum CU (MCU, % of baseline), maximum contrast upslope (%/s) and the delay to the maximum contrast upslope (s) were calculated. All lesions were classified histologically. The beginning of CU correlated significantly with the MCU delay in all lesions (P =.033). The frequency of a plateau phase was higher in malignant tumors compared to benign lesions (P =.031). Masses with a high MCU showed more frequently a washout of contrast medium after a plateau phase (P =.006) and a higher maximum contrast upslope (P b.001). The MCU delay time was shorter in adenocarcinoma than in squamous cell carcinoma (P =.004). These results indicate that dynamic contrast enhanced MRI might become instrumental in differentiating benign from malignant intrapulmonary tumors and distinguishing adenocarcinoma from squamous cell carcinoma.
📜 SIMILAR VOLUMES
## Abstract For longitudinal studies in patients suffering from cerebrovascular diseases the poor reproducibility of perfusion measurements via dynamic susceptibility‐weighted contrast‐enhanced MRI (DSC‐MRI) is a relevant concern. We evaluate a novel algorithm capable of overcoming limitations in D
## Abstract A noninvasive method to obtain high‐resolution images of tumor blood perfusion is needed for individualized cancer treatments. In this study we investigated the potential usefulness of dynamic contrast‐enhanced MRI (DCE‐MRI), using human melanoma xenografts as models of human cancer. Ga
## Abstract ## Purpose To assess whether dynamic contrast‐enhanced (DCE) MRI timing bolus data from routine clinical examinations can be postprocessed to obtain hepatic perfusion parameters for diagnosing cirrhosis. ## Materials and Methods We retrospectively identified 57 patients (22 with cirr
## Background: The objective of this study was to investigate the role of contrast-enhanced dynamic computed tomography (ct) in the evaluation of tumor angiogenesis in patients with lung carcinoma and to assess its importance in predicting tumor size and lymph node involvement. ## Methods: Dynami